CME Group Inc. (NASDAQ:CME) Shares Sold by Moran Wealth Management LLC

Moran Wealth Management LLC reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 46.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,947 shares of the financial services provider's stock after selling 19,385 shares during the period. Moran Wealth Management LLC's holdings in CME Group were worth $4,843,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Bellwether Advisors LLC bought a new position in CME Group in the 3rd quarter valued at $6,527,000. Portfolio Design Labs LLC bought a new stake in shares of CME Group in the third quarter worth about $2,058,000. Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of CME Group by 4.1% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 93,444 shares of the financial services provider's stock worth $20,618,000 after acquiring an additional 3,721 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of CME Group during the third quarter worth about $3,618,000. Finally, West Family Investments Inc. boosted its position in shares of CME Group by 31.0% during the third quarter. West Family Investments Inc. now owns 1,970 shares of the financial services provider's stock worth $435,000 after buying an additional 466 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of the company's stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company's stock, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company's stock, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,621 shares of company stock valued at $3,441,063. Insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CME shares. Piper Sandler raised their target price on shares of CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research note on Monday, October 28th. Morgan Stanley upped their price target on shares of CME Group from $210.00 to $233.00 and gave the company an "equal weight" rating in a research note on Thursday, October 17th. Citigroup upped their target price on CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research report on Thursday, October 24th. JPMorgan Chase & Co. increased their price objective on CME Group from $187.00 to $191.00 and gave the stock an "underweight" rating in a research report on Thursday, July 25th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $224.47.

CME Group Stock Down 0.2 %

Shares of CME Group stock traded down $0.40 during trading on Thursday, hitting $227.60. The company's stock had a trading volume of 332,151 shares, compared to its average volume of 1,906,099. The company has a market capitalization of $82.02 billion, a PE ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.74. The company has a fifty day simple moving average of $223.21 and a two-hundred day simple moving average of $210.81.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $2.25 EPS. The company's revenue was up 18.4% compared to the same quarter last year. Equities research analysts predict that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date of this dividend is Monday, December 9th. CME Group's dividend payout ratio (DPR) is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.